Serum sTfR Levels May Indicate Charge Profiling of Urinary r-hEPO in Doping Control

Medicine and Science in Sports and Exercise

Volumn 36, Issue 4, 2004, Pages 588-593

  Nissen Lie, Gro ^a   Birkeland, Kåre ^a   Hemmersbach, Peter ^a   Skibeli, Venke ^a  

^a AKER UNIVERSITY HOSPITAL   (Norway)

Author keywords

Charge pattern; Charge shift; Isoelectric focusing; Recombinant human EPO; Soluble transferrin receptor

Indexed keywords

ERYTHROPOIETIN; RECOMBINANT ERYTHROPOIETIN; SOLUBLE TRANSFERRIN RECEPTOR; TRANSFERRIN RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ATHLETE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOPING; DRUG MISUSE; HEMATOCRIT; HEMOGLOBIN DETERMINATION; HUMAN; IMMUNOBLOTTING; ISOELECTRIC FOCUSING; MALE; OXYGEN CONSUMPTION; PROTEIN BLOOD LEVEL; RETICULOCYTE; SERUM; URINALYSIS; URINE LEVEL;

BLOTTING, WESTERN; DOPING IN SPORTS; ERYTHROPOIESIS; ERYTHROPOIETIN, RECOMBINANT; HUMANS; ISOELECTRIC FOCUSING; MALE; NORWAY; PLACEBOS; RECEPTORS, TRANSFERRIN; SUBSTANCE ABUSE DETECTION;

EID: 1842453229     PISSN: 01959131     EISSN: None     Source Type: Journal    
DOI: 10.1249/01.MSS.0000121953.90379.A7     Document Type: Article

References (30)

1. ASHENDEN, M. J., C. J. GORE, R. PARISOTTO, K. SHARPE, W. G. HOPKINS, and A. G. HAHN. Effect of altitude on second-generation blood tests to detect erythropoietin abuse by athletes. Haematologica 88:1053-1062, 2003.
2. AUDRAN, M., and S. GAREAU. Effects of erythropoietin administration in training athletes and possible indirect detection in doping control. Med. Sci. Sports Exerc. 5:639-645, 1999.
3. BIRKELAND, K. I., J. STRAY-GUNDERSEN, P. HEMMERSBACH, J. HALLEN, and E. HAUG. Effect of rhEPO administration on serum levels of sTrR and cycling performance. Med. Sci. Sports Exerc. 32:1238-1243, 2000.
4. CASONI, I., G. RICCI, E. BALLARIN, et al. Heamtological indices of erythropoietin administration in athletes. Int J. Sports Med. 14:307-311, 1993.
5. CAZZOLA, M. A global strategy for prevention and detection of blood doping with erythropoietin and related drugs. Haematologica 85:561-563, 2000.
6. EKBLOM, B., and B. BERGLUND. Effect of erythropoietin administration on maximal aerobic power. Scand. J. Med. Sci. Sports 1:88-93, 1991.
7. ERSLEV, A. J. In vitro production of erythropoietin by kidneys perfused with a serum free solution. Blood 44:77-85, 1974.
8. GAREAU, S., M. AUDRAN, R. D. BAYNES, et al. Erythropoietin abuse in athletes. Nature 380:113, 1996.
9. GORE, C. J., R. PARISOTTO, M. J. ASHENDEN, et al. Second-generation blood tests to detect erythropoietin abuse by athletes. Haematologica 88:333-344, 2003.
10. IMAI, N., A. KAWAMURA, M. HIGUCHI, et al. Physicochemical and biological comparison of recombinant human erythropoietin with human urinary erythropoietin. J. Biochem. (Tokyo) 107:352-359, 1990.
11. JACOBS, K., C. SHOEMAKER, R. RUDERSDORF, et al. Isolation and characterization of genomic and cDNA clones of human erythropoietin. Nature 313:806-810, 1985.
12. JELKMANN, W. The enigma of the metabolic fate of circulating erythropoietin (Epo) in view of the pharmacokinetics of the recombinant drugs rhEPO and NESP. Eur. J. Haematol. 69:265-274, 2002.
13. LASNE, F. Double-blotting: a solution to the problem of non-specific binding of secondary antibodies in immunoblotting procedures. J. Immunol. Methods 253, 125-131, 2001.
14. LASNE, F., and J. DE CEAURRIZ. Recombinant erythropoietin in urine. Nature 405:635, 2000.
15. LASNE, F., L. MARTIN, N. CREPIN, and J. DE CEAURRIZ. Detection of isoelectric profiles of erythropoietin in urine: differentiation of natural and administrated recombinant hormones. Anal. Biochem. 311:119-126, 2002.
16. LIN, F. K., S. SUGGS, C. H. LIN, et al. Cloning and expression of the human erythropoietin gene. Proc. Natl. Acad. Sci. USA 82:7580-7584, 1985.
17. MALCOVATI, L., C. PASCUTTO, and M. CAZZOLA. Hematologic passport for athletes competing in endurance sports: a feasibility study. Haematologica 88:570-581, 2003.
18. NAKANISHI, T., R. MORIGUCHI, R. ITAHANA, Y. OTAKI, T. INOUE, and Y. TAKAMITSU. Acute effect of human recombinant erythropoietin administration on soluble transferrin receptor. Nephron 89:119-120, 2001.
19. NIKOLAIDIS, M. G., Y. MICHAILIDIS, and V. MOUGIOS. Variation of soluble transferrin receptor and ferritin concentrations in human serum during recovery from exercise. Eur. J. Appl. Physiol. 89:500-502, 2003.
20. NISSEN-LIE, G., P. HEMMERSBACH, G. TJØNNFJORD, P. TORJESEN, and V. SKIBELI. Charge analyses of human erythropoietin and analogues. In: Recent Advances in Doping Analysis: Proceedings of the Manfred Donike Workshop. Sport & Buch Strauß; W. Schänzer, H. Geyer, A. Gotzmann, and U. Mareck, (Eds.). 10:145-157, 2002.
21. PAREKH, R. B., R. A. DWEK, J. R. THOMAS, et al. Cell-type-specific and site-specific N-glycosylation of type I and type II human tissue plasminogen activator. Biochemistry 28:7644-7662, 1989.
22. PARISOTTO, R., C. J. GORE, K. R. EMSLIE, et al. A novel method utilising markers of altered erythropoiesis for the detection of recombinant human erythropoietin abuse in athletes. Haematologica 85:564-572, 2000.
23. PASCUAL, J. A., F. LASNE, C. HOWE, et al. Project for inter-laboratory comparison of the method for the detection of rhEPO in human urine, results, conclusion and current status. Recent Advances in Doping Analysis: Proceedings of the 20th Cologne Workshop on Dope Analysis, 2002. 10:235-144, 2002.
24. PASSING, H., and W. BABLOK. A new biometrical procedure for testing the equality of measurements from two different analytical methods: application of linear regression procedures for method comparison studies in clinical chemistry. Chem. Clin. Biochem. 21:709-720, 1983.
25. RUSSEL, G., C. J. GORE, M. J. ASHENDEN, R. PARISOTTO, and A. G. HAHN. Effects of prolonged low doses of recombinant human erythropoietin during submaximal and maximal exercise. Eur. J. Appl. Physiol. 86:442-449, 2002.
26. SKIBELI, V., G. NISSEN-LIE, and P. TORJESEN. Sugar profiling proves that human serum erythropoietin differs from recombinant human erythropoietin. Blood 98:3626-3634, 2001.
27. STORRING, P. L., and R. E. GAINES DAS. The International Standard for Recombinant DNA-derived erythropoietin: collaborative study of four recombinant DNA-derived erythropoietins and two highly purified human urinary erythropoietins. J. Endocrinol. 134:459-484, 1992.
28. WIDE, L., and C. BENGTSSON. Molecular charge heterogeneity of human serum erythropoietin. Br J. Haematol. 76:121-127, 1990.
29. WIDE, L., C. BENGTSSON, B. BERGLUND, and B. EKBLOM. Detection in blood and urine of recombinant erythropoietin administered to healthy men. Med. Sci. Sports Exerc. 27:1569-1576, 1995.
30. YEUNG, G. S., J. C. KJARSGAARD, and S. H. ZLOTKIN. Disparity of serum transferrin receptor measurements among different assay methods. Eur. J. Clin. Nutr. 52:801-804, 1998.